Pharmacokinetics and tolerability of deuterated-tetrabenazine (SD-809) and tetrabenazine in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 23 Mar 2013
At a glance
- Drugs Deutetrabenazine (Primary) ; Tetrabenazine
- Indications Drug-induced dyskinesia; Gilles de la Tourette's syndrome; Huntington's disease
- Focus Adverse reactions; Pharmacokinetics
- 23 Mar 2013 Results presented at the 65th Annual Meeting of the American Academy of Neurology.
- 05 Mar 2013 New trial record